Problems of differential diagnosis of focal brain lesions in patients with HIV infection
https://doi.org/10.22625/2072-6732-2020-12-1-35-39
Abstract
Currently, the leading cause of social disadaptations and disability of patients at advanced stages of HIV infection, as well as adverse outcomes, is the presence of severe comorbid variants of the course of HIV infection: HIV and co-infection of chronic viral hepatitis, tuberculosis, HIV and malignant tumors, and HIV-associated neurological diseases. In pediatric practice, the combination of HIV-induced and perinatal CNS lesions is the most relevant. The differential diagnosis of these conditions is complicated due to the polymorphism of clinical manifestations and the possibility of combining several pathological conditions simultaneously in patients. Neuroimaging data does not always have clear criteria for determining the exact cause of cerebral damage. The article presents data of own clinical neuroimaging observations of two patients with perinatal and parenteral HIV infection. The nervous system damage was polyetiological in nature and was presented in one case by a combination of HIV-encephalitis, cerebral toxoplasmosis and CNS lymphoma, in the second by the presence of Bourneville-Pringle disease (tuberous sclerosis) with the formation of giant-cell astrocytoma and HIV-induced brain damage. It should be noted that the optimization of the antiretroviral therapy regimen in the case of a combination of B-cell lymphoma and cerebral toxoplasmosis in a child with perinatal HIV infection led to clinical and laboratory remission
About the Authors
M. Yu. FominaRussian Federation
Saint-Petersburg
M. A. Titova
Russian Federation
Saint-Petersburg
References
1. Bougea A, Spantideas N, Galanis P, Gkekas G, Thomaides T. Optimal treatment of HIV-associated neurocognitive disorders: myths and reality. A critical review. Ther Adv Infect Dis. 2019 Apr 4;6: 2019 .
2. Ciacci J. D., Tellez C., VonRoenn J., Levy R. M. Lymphoma of the central nervous system in AIDS. Seminars in neurology, 1999, no. 19(2), pp. 213–221.
3. Pellegrino D, de Lima PP, de Oliveira ACP, Vidal JE. Hemorrhagic brain lesions in a newly diagnosed HIV-1 infected patient. Int J STD AIDS. 2019 Jun 3:956462419845965. doi: 10.1177/0956462419845965. [Epub ahead of print]
4. Ribera Pascuet E, López Aldeguer J, Pérez Elías MJ, Podzamczer Palter D. Cerebral toxoplasmosis Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:45-51.
5. Skiest D. J. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clinical Infectious Diseases, 2002, Jan., no. 34(1), pp. 103–115.
6. So Y. T., Beckstead J. H., Davis R. L. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Annals of Neurology, 1986, Nov., no. 20(5), pp. 566–572.
Review
For citations:
Fomina M.Yu., Titova M.A. Problems of differential diagnosis of focal brain lesions in patients with HIV infection. Journal Infectology. 2020;12(1):35-39. (In Russ.) https://doi.org/10.22625/2072-6732-2020-12-1-35-39